Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Irma Bakker-Woudenberg
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Disorders
Procedures
Anatomy
Sign-in to see full Profile
Network (preview)
24
ten Kate, Marian
21
van Vianen, Wim
15
Verbrugh, Henri
13
Storm, Gert
12
van Etten, Els
11
Schiffelers, Raymond
9
de Marie, Siem
9
Roosendaal, Robert
7
Becker, Martin
6
Fens, Marcel
6
van de Sande, Wendy
4
Van Belkum, Alex
4
Snijders, Susan
4
Mouton, Johan
3
Fahal, Ahmed
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Irma Bakker-Woudenberg (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: De Steenwinkel J E M; De Knegt G J; Ten Kate M T; Van Belkum A; Verbrugh H A; Hernandez-Pando R; Van Soolingen D; Bakker-Woudenberg I A J M
Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice.
International journal of immunopathology and pharmacology 2009;22(3):723-34.
-
2009: van de Sande Wendy W J; Mathot Ron A A; ten Kate Marian T; van Vianen Wim; Tavakol Mehri; Rijnders Bart J A; Bakker-Woudenberg Irma A J M
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
Antimicrobial agents and chemotherapy 2009;53(5):2005-13.
-
2008: van de Sande Wendy W J; van Vianen Wim; ten Kate Marian T; Vissers Jolanda; Laurijsens John; Tavakol Mehri; Rijnders Bart J A; Mathot Ron A A; Bakker-Woudenberg Irma A J M
Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2008;52(4):1345-50.
-
2007: de Steenwinkel Jurriaan E M; van Vianen Wim; Ten Kate Marian T; Verbrugh Henri A; van Agtmael Michiel A; Schiffelers Raymond M; Bakker-Woudenberg Irma A J M
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
The Journal of antimicrobial chemotherapy 2007;60(5):1064-73.
-
2007: Ahmed Abdalla A O; van de Sande Wendy W J; Fahal Ahmed; Bakker-Woudenberg Irma; Verbrugh Henri; van Belkum Alex
Management of mycetoma: major challenge in tropical mycoses with limited international recognition.
Current opinion in infectious diseases 2007;20(2):146-51.
-
2007: Goessens W H F; Mouton J W; ten Kate M T; Bijl A J; Ott A; Bakker-Woudenberg I A J M
Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
The Journal of antimicrobial chemotherapy 2007;59(3):507-16.
-
2006: Berbée Jimmy F P; van der Hoogt Caroline C; Kleemann Robert; Schippers Emile F; Kitchens Richard L; van Dissel Jaap T; Bakker-Woudenberg Irma A J M; Havekes Louis M; Rensen Patrick C N
Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(12):2162-4.
-
2006: Bakker-Woudenberg Irma A J M; ten Kate Marian T; Goessens Wil H F; Mouton Johan W
Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.
Antimicrobial agents and chemotherapy 2006;50(9):2919-25.
-
2006: Ruijgrok Elisabeth J; Fens Marcel H A M; Bakker-Woudenberg Irma A J M; van Etten Els W M; Vulto Arnold G
Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2006;50(5):1852-4.
-
2006: van Vianen Wim; de Marie Siem; ten Kate Marian T; Mathot Ron A A; Bakker-Woudenberg Irma A J M
Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
The Journal of antimicrobial chemotherapy 2006;57(4):732-40.
-
2006: Becker Martin J; De Marie Siem; Fens Marcel H A M; Haitsma Jack J; Verbrugh Henri A; Lachmann Burkhard; Bakker-Woudenberg Irma A J M
Pathophysiology of unilateral pulmonary aspergillosis in an experimental rat model.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44(2):133-9.
-
2005: Ruijgrok Elisabeth J; Fens Marcel H A; Bakker-Woudenberg Irma A J M; van Etten Els W M; Vulto Arnold G
Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activity.
The Journal of pharmacy and pharmacology 2005;57(10):1289-95.
-
2005: Bakker-Woudenberg Irma A J M; van Vianen Wim; van Soolingen Dick; Verbrugh Henri A; van Agtmael Michiel A
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
Antimicrobial agents and chemotherapy 2005;49(6):2387-98.
-
2005: van de Sande Wendy W J; Luijendijk Ad; Ahmed Abdalla O A; Bakker-Woudenberg Irma A J M; van Belkum Alex
Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
Antimicrobial agents and chemotherapy 2005;49(4):1364-8.
-
2005: Bakker-Woudenberg Irma A J M; Schiffelers Raymond M; Storm Gert; Becker Martin J; Guo Luke
Long-circulating sterically stabilized liposomes in the treatment of infections.
Methods in enzymology 2005;391():228-60.
-
2004: Ahmed Abdalla O A; van de Sande Wendy W J; van Vianen Wim; van Belkum Alex; Fahal Ahmed H; Verbrugh Henri A; Bakker-Woudenberg Irma A J M
In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
Antimicrobial agents and chemotherapy 2004;48(7):2742-6.
-
2003: Becker Martin J; de Marie Siem; Fens Marcel H A M; Verbrugh Henri A; Bakker-Woudenberg Irma A J M
Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis.
The Journal of antimicrobial chemotherapy 2003;52(3):428-34.
-
2003: Bakker-Woudenberg Irma A J M
Experimental models of pulmonary infection.
Journal of microbiological methods 2003;54(3):295-313.
-
2003: Ahmed Abdalla O; van Vianen Wim; ten Kate Marian T; van de Sande Wendy W J; van Belkum Alex; Fahal Ahmed H; Verbrugh Henri A; Bakker-Woudenberg Irma A J M
A murine model of Madurella mycetomatis eumycetoma.
FEMS immunology and medical microbiology 2003;37(1):29-36.
-
2002: Bakker-Woudenberg Irma A J M; ten Kate Marian T; Guo Luke; Working Peter; Mouton Johan W
Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.
Antimicrobial agents and chemotherapy 2002;46(8):2575-81.
-
2002: Becker Martin J; de Marie Siem; Fens Marcel H A M; Hop Wim C J; Verbrugh Henri A; Bakker-Woudenberg Irma A J M
Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response.
The Journal of antimicrobial chemotherapy 2002;49(5):813-20.
-
2002: Bakker-Woudenberg Irma A J M
Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci.
International journal of antimicrobial agents 2002;19(4):299-311.
-
2002: Stearne Lorna E T; Schiffelers Raymond M; Smouter Edwin; Bakker-Woudenberg Irma A J M; Gyssens Inge C
Biodistribution of long-circulating PEG-liposomes in a murine model of established subcutaneous abscesses.
Biochimica et biophysica acta 2002;1561(1):91-7.
-
2002: Schiffelers Raymond M; Storm Gert; ten Kate Marian T; Stearne-Cullen Lorna E T; den Hollander Jan G; Verbrugh Henri A; Bakker-Woudenberg Irma A J M
Liposome-enabled synergistic interaction of antimicrobial agents.
Journal of liposome research 2002;12(1-2):121-7.
-
2002: Becker Martin J; Dams Els Th M; de Marie Siem; Oyen Wim J G; Boerman Otto C; Fens Marcel H A M; Verbrugh Henri A; Bakker-Woudenberg Irma A J M
Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats.
Nuclear medicine and biology 2002;29(2):177-84.
-
2001: Schiffelers R; Storm G; Bakker-Woudenberg I
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies.
The Journal of antimicrobial chemotherapy 2001;48(3):333-44.
-
2001: Schiffelers R M; Storm G; ten Kate M T; Stearne-Cullen L E; den Hollander J G; Verbrugh H A; Bakker-Woudenberg I A
In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.
The Journal of pharmacology and experimental therapeutics 2001;298(1):369-75.
-
2001: Schiffelers R M; Storm G; Bakker-Woudenberg I A
Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue.
Pharmaceutical research 2001;18(6):780-7.
-
2001: Bakker-Woudenberg I A; ten Kate M T; Guo L; Working P; Mouton J W
Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
Antimicrobial agents and chemotherapy 2001;45(5):1487-92.
-
2001: Schiffelers R M; Storm G; Bakker-Woudenberg I A
Therapeutic efficacy of liposomal gentamicin in clinically relevant rat models.
International journal of pharmaceutics 2001;214(1-2):103-5.
-
2001: Schiffelers R M; Storm G; ten Kate M T; Bakker-Woudenberg I A
Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.
Antimicrobial agents and chemotherapy 2001;45(2):464-70.
-
2001: Stearne L E; Kooi C; Goessens W H; Bakker-Woudenberg I A; Gyssens I C
In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique.
Antimicrobial agents and chemotherapy 2001;45(1):243-51.
-
2000: Schiffelers R M; Bakker-Woudenberg I A; Storm G
Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly(ethylene)glycol coating.
Biochimica et biophysica acta 2000;1468(1-2):253-61.
-
2000: Becker M J; de Marie S; Willemse D; Verbrugh H A; Bakker-Woudenberg I A
Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model.
Journal of clinical microbiology 2000;38(4):1434-8.
-
2000: Van Etten E W; Stearne-Cullen L E; ten Kate M; Bakker-Woudenberg I A
Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.
Antimicrobial agents and chemotherapy 2000;44(3):540-5.
-
1999: Dams E T; Becker M J; Oyen W J; Boerman O C; Storm G; Laverman P; de Marie S; van der Meer J W; Bakker-Woudenberg I A; Corstens F H
Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2066-72.
-
1999: Schiffelers R M; Bakker-Woudenberg I A; Snijders S V; Storm G
Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics.
Biochimica et biophysica acta 1999;1421(2):329-39.
-
1998: ten Hagen T L; van Vianen W; Heremans H; Bakker-Woudenberg I A
Differential nitric oxide and TNF-alpha production of murine Kupffer cell subfractions upon priming with IFN-gamma and TNF-alpha.
Liver 1998;18(5):299-305.
-
1998: van Etten E W; van Vianen W; Hak J; Bakker-Woudenberg I A
Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.
Antimicrobial agents and chemotherapy 1998;42(9):2437-9.
-
1998: van Etten E W; Snijders S V; van Vianen W; Bakker-Woudenberg I A
Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice.
Antimicrobial agents and chemotherapy 1998;42(9):2431-3.
-
1998: de Bruijn M F; van Vianen W; Ploemacher R E; Bakker-Woudenberg I A; Campbell P A; van Ewijk W; Leenen P J
Bone marrow cellular composition in Listeria monocytogenes infected mice detected using ER-MP12 and ER-MP20 antibodies: a flow cytometric alternative to differential counting.
Journal of immunological methods 1998;217(1-2):27-39.
-
1998: van Etten E W; ten Kate M T; Snijders S V; Bakker-Woudenberg I A
Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.
Antimicrobial agents and chemotherapy 1998;42(7):1677-81.
-
1998: ten Hagen T L; van Vianen W; Savelkoul H F; Heremans H; Buurman W A; Bakker-Woudenberg I A
Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon.
Infection and immunity 1998;66(5):1962-7.
-
1998: Storm G; ten Kate M T; Working P K; Bakker-Woudenberg I A
Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):111-5.
-
1996: Leenders A C; de Marie S; ten Kate M T; Bakker-Woudenberg I A; Verbrugh H A
Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.
The Journal of antimicrobial chemotherapy 1996;38(2):215-25.
-
1996: ten Hagen T L; van Vianen W; Bakker-Woudenberg I A
Isolation and characterization of murine Kupffer cells and splenic macrophages.
Journal of immunological methods 1996;193(1):81-91.
-
1996: den Hollander J G; Mouton J W; Bakker-Woudenberg I A; Vleggaar F P; van Goor M P; Verbrugh H A
Enzymatic method for inactivation of aminoglycosides during measurement of postantibiotic effect.
Antimicrobial agents and chemotherapy 1996;40(2):488-90.
-
1995: van Etten E W; Chander H R; Snijders S V; Bakker-Woudenberg I A
Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
The Journal of antimicrobial chemotherapy 1995;36(6):961-74.
-
1995: ten Hagen T L; Vossen A C; van Vianen W; Tibbe G J; Savelkoul H F; Heremans H; Bakker-Woudenberg I A
Enhancement of nonspecific resistance by liposome-encapsulated immunomodulators does not affect skin graft rejection in mice.
Transplantation 1995;60(11):1211-4.
-
1995: van Etten E W; ten Kate M T; Stearne L E; Bakker-Woudenberg I A
Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
Antimicrobial agents and chemotherapy 1995;39(9):1954-8.
-
1995: Daemen T; Hofstede G; Ten Kate M T; Bakker-Woudenberg I A; Scherphof G L
Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages.
International journal of cancer. Journal international du cancer 1995;61(5):716-21.
-
1995: Bakker-Woudenberg I A; ten Kate M T; Stearne-Cullen L E; Woodle M C
Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue.
The Journal of infectious diseases 1995;171(4):938-47.
-
1995: ten Hagen T L; van Vianen W; Bakker-Woudenberg I A
Modulation of nonspecific antimicrobial resistance of mice to Klebsiella pneumoniae septicemia by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon-gamma alone or combined.
The Journal of infectious diseases 1995;171(2):385-92.
-
1995: Bergers J J; ten Hagen T L; van Etten E W; Bakker-Woudenberg I A
Liposomes as delivery systems in the prevention and treatment of infectious diseases.
Pharmacy world & science : PWS 1995;17(1):1-11.
-
1994: de Marie S; Janknegt R; Bakker-Woudenberg I A
Clinical use of liposomal and lipid-complexed amphotericin B.
The Journal of antimicrobial chemotherapy 1994;33(5):907-16.
-
1994: Melissen P M; van Vianen W; Bakker-Woudenberg I A
Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.
Antimicrobial agents and chemotherapy 1994;38(1):147-50.
-
1994: Bakker-Woudenberg I A; Storm G; Woodle M C
Liposomes in the treatment of infections.
Journal of drug targeting 1994;2(5):363-71.
-
1993: van Etten E W; van den Heuvel-de Groot C; Bakker-Woudenberg I A
Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.
The Journal of antimicrobial chemotherapy 1993;32(5):723-39.
-
1993: Bakker-Woudenberg I A; Lokerse A F; ten Kate M T; Mouton J W; Woodle M C; Storm G
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.
The Journal of infectious diseases 1993;168(1):164-71.
-
1993: Bakker-Woudenberg I A; Lokerse A F; ten Kate M T; Melissen P M; van Vianen W; van Etten E W
Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12 Suppl 1():S61-7.
-
1993: Melissen P M; van Vianen W; Bidjai O; van Marion M; Bakker-Woudenberg I A
Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monocytogenes.
Biotherapy (Dordrecht, Netherlands) 1993;6(2):113-24.
-
1993: Melissen P M; van Vianen W; Leenen P J; Bakker-Woudenberg I A
Tissue distribution and cellular distribution of liposomes encapsulating muramyltripeptide phosphatidyl ethanolamide. Tissue and cellular distribution of LE-MTPPE.
Biotherapy (Dordrecht, Netherlands) 1993;7(1):71-8.
-
1992: Melissen P M; van Vianen W; Bakker-Woudenberg I A
Roles of peripheral leukocytes and tissue macrophages in antibacterial resistance induced by free or liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.
Infection and immunity 1992;60(11):4891-7.
-
1992: Bakker-Woudenberg I A; Lokerse A F; ten Kate M T; Storm G
Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue.
Biochimica et biophysica acta 1992;1138(4):318-26.
-
1992: Melissen P M; van Vianen W; Rijsbergen Y; Bakker-Woudenberg I A
Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection.
Infection and immunity 1992;60(1):95-101.
-
1991: Roosendaal R; Bakker-Woudenberg I A; van den Berghe-van Raffe M; Vink-van den Berg J C; Michel M F
Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(12):1019-25.
-
1991: van Etten E W; van de Rhee N E; van Kampen K M; Bakker-Woudenberg I A
Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
Antimicrobial agents and chemotherapy 1991;35(11):2275-81.
-
1990: Bakker-Woudenberg I A; Roosendaal R
Impact of dosage schedule of antibiotics on the treatment of serious infections.
Intensive care medicine 1990;16 Suppl 3():S229-34.
-
1990: Bakker-Woudenberg I A; Lokerse A F
Liposomes and lipid carriers in the treatment of microbial infections.
Scandinavian journal of infectious diseases. Supplementum 1990;74():34-41.
-
1990: Roosendaal R; Bakker-Woudenberg I A
Impact of the antibiotic dosage schedule on efficacy in experimental lung infections.
Scandinavian journal of infectious diseases. Supplementum 1990;74():155-62.
-
1990: Bakker-Woudenberg I A; Lokerse A F; ten Kate M
Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes.
Scandinavian journal of infectious diseases. Supplementum 1990;74():54-7.
-
1989: Roosendaal R; Bakker-Woudenberg I A; van den Berghe-van Raffe M; Vink-van den Berg J C; Michel B M
Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(10):878-87.
-
1989: Bakker-Woudenberg I A; Lokerse A F; Roerdink F H
Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
The Journal of pharmacology and experimental therapeutics 1989;251(1):321-7.
-
1989: Bakker-Woudenberg I A; Lokerse A F; Vink-van den Berg J C; Roerdink F H
Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):603-9.
-
1988: Bakker-Woudenberg I A; Lokerse A F; Roerdink F H
Effect of lipid composition on activity of liposome-entrapped ampicillin against intracellular Listeria monocytogenes.
Antimicrobial agents and chemotherapy 1988;32(10):1560-4.
-
1988: Bakker-Woudenberg I A; Roosendaal R
Impact of dosage regimens on the efficacy of antibiotics in the immunocompromised host.
The Journal of antimicrobial chemotherapy 1988;21(2):145-7.
-
1988: Bakker-Woudenberg I A; Lokerse A F; Vink-van den Berg J C; Roerdink F H
Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro.
Infection 1988;16 Suppl 2():S165-70.
-
1987: Roosendaal R; Bakker-Woudenberg I A; van den Berghe-van Raffe M; Vink-van den Berg J C; Michel M F
Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
Pharmaceutisch weekblad. Scientific edition 1987;9 Suppl():S33-40.
-
1987: Roosendaal R; Bakker-Woudenberg I A; van den Berghe-van Raffe M; Vink-van den Berg J C; Michel M F
Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
Antimicrobial agents and chemotherapy 1987;31(11):1809-15.
-
1986: Roosendaal R; Bakker-Woudenberg I A; van den Berghe-van Raffe M; Michel M F
Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.
Antimicrobial agents and chemotherapy 1986;30(3):403-8.
-
1986: Bakker-Woudenberg I A; Lokerse A F; Vink-van den Berg J C; Roerdink F H; Michel M F
Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages.
Antimicrobial agents and chemotherapy 1986;30(2):295-300.
-
1986: Bakker-Woudenberg I A; Roerdink F H
Antimicrobial chemotherapy directed by liposomes.
The Journal of antimicrobial chemotherapy 1986;17(5):547-9.
-
1985: Bakker-Woudenberg I A; van den Berg J C; Vree T B; Baars A M; Michel M F
Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.
Antimicrobial agents and chemotherapy 1985;28(5):654-9.
-
1985: Roosendaal R; Bakker-Woudenberg I A; van den Berg J C; Michel M F
Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats.
The Journal of infectious diseases 1985;152(2):373-8.
-
1985: Bakker-Woudenberg I A; Lokerse A F; Roerdink F H; Regts D; Michel M F
Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice.
The Journal of infectious diseases 1985;151(5):917-24.
-
1984: Bakker-Woudenberg I A; van den Berg J C; Fontijne P; Michel M F
Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats.
European journal of clinical microbiology 1984;3(2):131-5.
-
1982: Bakker-Woudenberg I A; van den Berg J C; Michel M F
Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
Antimicrobial agents and chemotherapy 1982;22(6):1042-50.
Sign-in to see more
